As of May 26
| +0.0148 / +2.50%|
The 4 analysts offering 12-month price forecasts for Synthetic Biologics Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +559.20% increase from the last price of 0.61.
The current consensus among 4 polled investment analysts is to Buy stock in Synthetic Biologics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.